Elixirgen Therapeutics, Inc.
2 clinical trials · Sponsor
◉ Watch Elixirgen Therapeutics, Inc.
| Record | Firm | Date |
|---|---|---|
| Rollover Study From EXG-US-01 (NCT05868499) | Elixirgen Therapeutics, Inc. | 2024-01-01 |
| Study to Evaluate of EXG34217 in Patients With Telomere Biology Disorders With Bone Marrow Failure (NCT04211714) | Elixirgen Therapeutics, Inc. | 2021-04-08 |
Track Elixirgen Therapeutics, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.